STOCK TITAN

SGHT Form 144: 591 Shares from Restricted Stock Vest on 09/30/2025

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Sight Sciences, Inc. filing a Form 144 reports a proposed sale of 591 common shares with an aggregate market value of $1,992.32. The seller acquired these shares on 09/30/2025 through restricted stock vesting and the payment type is listed as compensation. The proposed approximate sale date is 10/06/2025 on NASDAQ. The filing shows 52,367,359 shares outstanding for the issuer and indicates no sales by the seller in the past three months. The filer attests there is no undisclosed material adverse information and includes the standard signature and legal notice language.

Positive

  • Clear disclosure of share count (591) and aggregate value ($1,992.32)
  • Acquisition and payment details provided (vested restricted stock on 09/30/2025; payment = compensation)
  • Broker named for execution (Fidelity Brokerage Services LLC) enabling traceability of transaction

Negative

  • No material negatives evident; transaction size is immaterial relative to 52,367,359 shares outstanding

Insights

Routine insider sale notice tied to equity compensation.

The filing documents a small, specified offer to sell 591 shares that vested as restricted stock on 09/30/2025, with proceeds shown as $1,992.32. This is a standard Rule 144 notice indicating the holder intends to sell restricted or control securities through a broker.

The main compliance dependencies are the continued availability of Rule 144 resale conditions (public information, holding period, volume limits) and execution on the indicated date 10/06/2025. Watch confirmations of sale execution and any subsequent Form 4 or Form 5 filings that would report the actual disposition within the statutory timelines.

Transaction is immaterial to market capitalization but relevant for insider trading records.

The proposed sale size is de minimis versus the issuer's 52,367,359 outstanding shares, so it’s unlikely to impact market price or liquidity. The use of a major broker (Fidelity Brokerage Services LLC) signals a normal brokerage execution.

Investors or compliance teams should note the acquisition date and nature (09/30/2025, restricted stock vesting) for vesting and tax timelines and confirm whether proceeds are treated as compensation on tax reporting for the recipient.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 filed by Sight Sciences (SGHT) report?

It reports a proposed sale of 591 common shares with an aggregate market value of $1,992.32, expected to be sold on 10/06/2025 on NASDAQ.

How were the shares acquired according to the filing for SGHT?

The shares were acquired on 09/30/2025 via restricted stock vesting and the filing lists payment as compensation.

Does the Form 144 show prior sales by the seller in the past three months?

No. The filing states "Nothing to Report" for securities sold during the past three months.

What broker is handling the proposed sale in the SGHT Form 144?

The named broker is Fidelity Brokerage Services LLC located in Smithfield, RI.

How large is the issuer's share base reported in the filing?

The filing indicates 52,367,359 shares outstanding for the issuer.
Sight Sciences, Inc.

NASDAQ:SGHT

SGHT Rankings

SGHT Latest News

SGHT Latest SEC Filings

SGHT Stock Data

446.24M
41.81M
20.66%
50.37%
1.99%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
MENLO PARK